Clinical Trial Update: Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two different doses of irinotecan in combination with cisplatin for extensive-disease small cell lung cancer; the trial status is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Cisplatin (Platinol) (cisplatin)
• Irinotecan (Camptosar) (Irinotecan)

Snippet

Sponsor: Third Military Medical University | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN